Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: Thai Chung who wrote (2936)	3/1/1999 8:57:00 AM
From: WHL	Read Replies (1) \| Respond to of 3725

This is intelligent divestment of non-productive assets that IMAT does not have the capital to develop. The alliance with GE is paying off in ways that were not to be anticipated (capitalizing the purchase of HeartScan sites by unrelated 3rd parties). Things are looking good! This should help stem the flow of new share certificates to finance the HeartScan debacle. A little improvement in SE Asia, a little less HeartScan, some share repurchases (I wish), a little operating profit and presto- IMAT gets back over $1.75.